Literature DB >> 33731267

Assessment of outcomes in autism clinical trials over the course of development.

Geraldine Dawson1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33731267      PMCID: PMC8238809          DOI: 10.1016/j.euroneuro.2021.02.018

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   5.415


× No keyword cloud information.
  9 in total

1.  Event-related brain potentials reveal anomalies in temporal processing of faces in autism spectrum disorder.

Authors:  James McPartland; Geraldine Dawson; Sara J Webb; Heracles Panagiotides; Leslie J Carver
Journal:  J Child Psychol Psychiatry       Date:  2004-10       Impact factor: 8.982

2.  Placebo-like response in absence of treatment in children with Autism.

Authors:  Rebecca M Jones; Caroline Carberry; Amarelle Hamo; Catherine Lord
Journal:  Autism Res       Date:  2017-04-12       Impact factor: 5.216

3.  Potential for Digital Behavioral Measurement Tools to Transform the Detection and Diagnosis of Autism Spectrum Disorder.

Authors:  Geraldine Dawson; Guillermo Sapiro
Journal:  JAMA Pediatr       Date:  2019-04-01       Impact factor: 16.193

4.  Atypicality of the N170 Event-Related Potential in Autism Spectrum Disorder: A Meta-analysis.

Authors:  Erin Kang; Cara M Keifer; Emily J Levy; Jennifer H Foss-Feig; James C McPartland; Matthew D Lerner
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-11-21

5.  Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II.

Authors:  C H Chatham; K I Taylor; T Charman; X Liogier D'ardhuy; E Eule; A Fedele; A Y Hardan; E Loth; L Murtagh; M Del Valle Rubido; A San Jose Caceres; J Sevigny; L Sikich; L Snyder; J E Tillmann; P E Ventola; K L Walton-Bowen; P P Wang; T Willgoss; F Bolognani
Journal:  Autism Res       Date:  2017-09-21       Impact factor: 5.216

6.  Developing Clinically Practicable Biomarkers for Autism Spectrum Disorder.

Authors:  James C McPartland
Journal:  J Autism Dev Disord       Date:  2017-09

Review 7.  An update on pharmacotherapy of autism spectrum disorder in children and adolescents.

Authors:  Ritu Goel; Ji Su Hong; Robert L Findling; Na Young Ji
Journal:  Int Rev Psychiatry       Date:  2018-04-25

8.  Social attention: a possible early indicator of efficacy in autism clinical trials.

Authors:  Geraldine Dawson; Raphael Bernier; Robert H Ring
Journal:  J Neurodev Disord       Date:  2012-05-17       Impact factor: 4.025

9.  An Observational Study With the Janssen Autism Knowledge Engine (JAKE®) in Individuals With Autism Spectrum Disorder.

Authors:  Seth L Ness; Abigail Bangerter; Nikolay V Manyakov; David Lewin; Matthew Boice; Andrew Skalkin; Shyla Jagannatha; Meenakshi Chatterjee; Geraldine Dawson; Matthew S Goodwin; Robert Hendren; Bennett Leventhal; Frederick Shic; Jean A Frazier; Yvette Janvier; Bryan H King; Judith S Miller; Christopher J Smith; Russell H Tobe; Gahan Pandina
Journal:  Front Neurosci       Date:  2019-02-27       Impact factor: 4.677

  9 in total
  1 in total

1.  Patterns of Intervention Utilization Among School-Aged Children with Autism Spectrum Disorder: Findings from a Multi-Site Research Consortium.

Authors:  Aksheya Sridhar; Jocelyn Kuhn; Susan Faja; Maura Sabatos-DeVito; Julia I Nikolaeva; Geraldine Dawson; Charles A Nelson; Sara J Webb; Raphael Bernier; Shafali Jeste; Katarzyna Chawarska; Catherine A Sugar; Frederick Shic; Adam Naples; James Dziura; James C McPartland
Journal:  Res Autism Spectr Disord       Date:  2022-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.